Dr. Laila M. Matalqah Ph.D. Pharmacology PHARMACOLOGY OF CNS part 1 General Pharmacology M212.

Slides:



Advertisements
Similar presentations
Drugs acting on the CNSI
Advertisements

Prof Graeme Henderson Department of Pharmacology C32 Medical Sciences Building Anticholinergics Opioids Benzodiazepines and.
Sedative – Hypnotic Drugs
Drugs That Act On The Central Nervous System SAMUEL AGUAZIM( MD)
ILOs At the end of this lecture you will be able to:- Recognize the symptoms and pathophysiology of parkinsonism. Understand the pharmacology of drugs.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 34 Sedative-Hypnotic Drugs.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 11 Antianxiety Agents.
Antianxiety drugs Prof. Hanan H. Hagar Pharmacology Department College of Medicine.
Anxiolytic & Hypnotic Drugs
CNS depressants CNS depressants
Sedative-Hypnotic Drugs and Alcohol
Sedative Hypnotics and anxiolytics
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 16 Antiparkinsonian Drugs.
Anti-Anxiety Agents and Sedative-Hypnotics
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 14 Antiparkinsonian Drugs.
Chapter 30 Agents Used to Treat Parkinson’s Disease.
Sedatives – Hypnotics.  1) CNS depressants are usually not obtained illicitly and self-administered but rather are prescribed under the direction of.
PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES
Drugs for Parkinon’s disease Parkinson's disease –progressive tremor –Bradykinesia and rigidity –degeneration of the dopaminergic nigrostriatal pathway.
Drugs of Anti-Parkinson’s disease Department of Pharmacology Zhang Yan-mei.
Anti-Anxiety Agents and Sedative-Hypnotics
Chapter 31 Anti-Parkinson Agents. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Parkinson’s.
By Prof. Hanan Hagar Pharmacology unit Medical College.
Drugs used in anxiety and panic disorders Prof. Hanan Hagar Pharmacology Unit College of Medicine.
Sedative-Hypnotic Drugs
Anti-Anxiety Medications Brian Ladds, M.D.. Anti-Anxiety Medications 1903: first barbiturate introduced in U.S. –e.g., pentobarbital (Nembutal), amobarbital.
Tranquilizers & Sedative-Hypnotics
Drugs For Parkinson's Disease. History of Parkinson's Disease l First characterized in 1817 by James Parkinson : An Essay On The Shaking Palsy.
Drugs used in treatment of addiction
Drugs Used in Mental Health Antianxiety Drugs. Anxiety – a feeling of apprehension, worry, or uneasiness that may or may not e based on reality Anxiolytics.
CNS Depressants Lab # 2.
Drugs used in Anxiety & Panic Disorders
Drugs used in parkinsonism
By Prof. Hanan Hagar Pharmacology unit Medical College.
Sedative-Hypnotic Drugs
By Prof. Hanan Hagar Pharmacology unit Medical College.
DH206 Pharmacology Chapter 11: Antianxiety Agents Lisa Mayo, RDH, BSDH Copyright © 2011, 2007 Mosby, Inc., an affiliate of Elsevier. All rights reserved.
Anxiolytic , Sedative and Hypnotic Drugs
1 Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. Chapter 23 DRUGS FOR NEUROLOGIC DISORDERS: PARKINSONISM AND ALZHEIMER’S DISEASE.
SEDATIVES, HYPNOTICS & ANXIOLYTICS
Parkinson's Disease ILOs
Drugs in parkinsonism ilos
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 14 Antiparkinsonian Drugs.
Sedatives, Hypnotics & Anxiolytics. BARBITURATES Derivatives of Barbituric Acid Barbituric acid itself has no sedative effect No more used as sedative.
ANTI- PARKINSONISM Dr: Samah Gaafar Al-shaygi.  Neurodegenerative diseases.  Dopamenergic neurones in substantia nigra.  Environmental* genetic factors.
 Parkinson’s disease is a neurodegenerative disorder first described by Dr James Parkinson, a London physician, in The underlying cause is loss.
ANTI-PARKINSONIAN DRUGS. Parkinsonism It is a common movement disorder that involves dysfunction in the basal ganglia and associated brain structures.
Drugs used in anxiety and panic disorders
Anxiolytic , Sedative and Hypnotic Drugs
Drugs acting on the CNS. Nervous System CNS PNS Somatic Autonomic Parasympathetic Sympathetic.
Pharmacology Nursing C ONTINUE CNS D RUGS Lecture 7.
Drugs Used for Parkinson’s Disease
Parkinsonism.
Drugs used for anxiety and panic disorders
Drugs used for anxiety and panic disorders
DRUGS FOR PARKINSONISM
Anxiolytics, Sedatives and Hypnotic
Drugs of Anti-Parkinson’s disease
Central Nervous System Drugs: Part 1 Autonomic Nervous System Drugs Drugs Used to treat Seizures Drugs Used to treat Parkinson’s Disease Analgesics.
Drugs for Parkinson’s Disease
Sedative-Hypnotic Drugs
Jeopardy Final Jeopardy Barbiturates $100 $100 $100 $100 $100 $200
Treatment of Parkinson’s disease
Central Nervous System
Anxiolytic, Sedative and Hypnotic Drugs
Anti-parkinsonism Drugs
CNS Depressants Lab # 2.
Anti-parkinsonism Drugs
Anxiolytic and hypnotic drugs
Anxiolytic, Sedative and Hypnotic Drugs
Presentation transcript:

Dr. Laila M. Matalqah Ph.D. Pharmacology PHARMACOLOGY OF CNS part 1 General Pharmacology M212

CNS drugs Classification: I. Central Stimulants Drugs which increase the activating functions of CNS II. Central Depressants Drugs that decrease the activation of CNS Most commonly use in therapy

CNS pharmacology Neurodegenerative disorders : Parkinson disease Alzheimer disease Anxiolytics and hypnotics: Drugs that induce sleep Antidepressants Opioid analgesics: relieve pain and sleep Anticonvulsant: Drugs used to treat epilipsy Antipsychotic drugs Anesthetics

A. Excitatory pathways 1. Stimulation of an excitatory neuron causes the release of neurotransmitter molecules, such as glutamate or acetylcholine, 2. The influx of Na+ causes a weak depolarization effect 3. If the number of stimulated excitatory neurons increases, more excitatory neurotransmitter is released Neurotransmission in CNS

B. Inhibitory pathways 1. Stimulation of inhibitory neurons releases neurotransmitter molecules, such as γ -aminobutyric acid (GABA), glycine or dopamine 2. The influx of Cl– and efflux of K+ cause a weak hyperpolarization. This diminishes the generation of action potentials

Excitatory pathwaysInhibitory pathways

1. Parkinson Disease Parkinsonism is a progressive neurological disorder of muscle movement, characterized: 1. Tremors, 2. Muscular rigidity, 3. Bradykinesia (slowness in initiating and carrying out voluntary movements) 4. postural abnormalities. Etiology: 1. Reduction of activity of dopaminergic (inhibitory pathway in the based ganglia and substania nigra 2. Increased activity of cholinergic (excitatory) fibers in the based ganglia

Drugs Used In Parkinson Disease A. Increase dopaminergic activity: Levodopa and carbidopa Levodopa is a metabolic precursor of dopamine Dopamine itself does not cross the blood-brain barrier, but levodopa, is actively transported into the CNS and is converted to dopamine in the brain Levodopa is decarboxylated to dopamine in the periphery, resulting in side effects that include nausea, vomiting, cardiac arrhythmias, and hypotension. So?

Carbidopa: Carbidopa, a dopa decarboxylase inhibitor Inhibit the metabolism of levodopa in the GIT and peripheral tissues increasing the availability of levodopa to the CNS decrease the dose of levodopa needed by 4-5 times decreases side effects. Actions: levodopa–carbidopa (Sinemet®) decreases the rigidity, tremors, and other symptoms of parkinsonism Drugs Used In Parkinson Disease

Adverse effects: Peripheral effects: 1. Anorexia, nausea, and vomiting: CTZ stimulation 2. Tachycardia: dopaminergic action 3. Mydriasis: Adrenergic action 4. Saliva and urine are a brownish color CNS effects: 1. Visual and auditory hallucinations and abnormal 2. involuntary movements (dyskinesias) 3. Mood change Drugs Used In Parkinson Disease

Ph/KDrug interaction Levodopa has an extremely short half-life (1 to 2 hours) levodopa should be taken on an empty stomach, typically 45 minutes before a meal. Withdrawal from the drug must be gradual. The vitamin pyridoxine (B6) increases the peripheral breakdown of levodopa and diminishes its effectiveness Drugs Used In Parkinson Disease

B. Dopamine-receptor agonists 1. Bromocriptine 2. Apomorphine 3. Rotigotine S/e : same like levodopa C. Anticholinergic agents Benztropine and Benzhexol an adjuvant role in antiparkinsonism therapy. S/e: pupillary dilation, confusion, sinus tachycardia, urinary retention, constipation, and dry mouth Drugs Used In Parkinson Disease

D. Selegiline MOA: inhibits MAO Type B (which metabolizes dopamine) at low to moderate doses S/E: insomnia E. Amantadine antiviral drug in the treatment of influenza MOA: increase the release of dopamine, blocking cholinergic receptors The drug has little effect on tremor, but it is more effective than the anticholinergics against rigidity and bradykinesia Drugs Used In Parkinson Disease

2. Anxiolytics and Hypnotic Drugs Anxiety: is a state of tension, apprehension, or uneasiness (a fear that seems to arise from a unknown source). The physical symptoms of severe anxiety are similar to those of fear (such as tachycardia, sweating, trembling, and palpitations) and involve sympathetic activation. Anxiolytics Drugs I. Benzodiazepines II. Barbiturates III. Others: Chloral Hydrate

Benzodiazepines MOA: Activate (GABA A ) receptors (inhibitory NT) Binding of GABA to its receptor triggers an open ing of a chloride channel Therapeutic Actions 1. Reduction of anxiety: at low doses, the benzodiazepines are anxiolytic ( α2-GABA) E.g., clonazepam, lorazepam and diazepam 2. Sedative and hypnotic actions at higher doses. ( α1-GABA) Temazepam and Flurazepam 3. Anticonvulsant: to treat epilepsy e.g.,, lorazepam and diazepam ( α1- GABA) 4. Muscle relaxant: At high doses: e.x: Diazepam for multiple sclerosis

Benzodiazepines Long-acting: Clonazepam Diazepam Flurazepam Intermediate acting: Alprazolam Lorazepam Temazepam Short-acting: Oxazepam Triazolam

Benzodiazepines Adverse effect 1. Drowsiness and confusion 2. Psychological and physical dependence on benzodiazepines can develop if high doses of the drugs are given over a prolonged period 3. Abrupt discontinuation of the benzodiazepines results in withdrawal symptoms, including confusion, anxiety, agitation, restlessness, insomnia. Overdoses toxicity: Flumazenil is a GABA-receptor antagonist that can rapidly reverse the effects of benzodiazepines

2. Barbiturates MOA: Bind GABA A receptors, which enhances GABAergic transmission Therapeutic Actions 1. Anticonvulsant: Phenobarbital is used in long-term management of seizures 2. Anesthesia: thiopental, are used intravenously to induce anesthesia. which acts within seconds and has a duration of action of about 30 minutes, is used in the 3. sedative and hypnotic: Pentobarbital, secobarbital and amobarbital are short-acting barbiturates, suppress REM sleep 2. Hypnotic and anxiolytics Drugs

Pharmacokinetics: Enzyme induction: Barbiturates induce CYP450 in the liver. Side effects: 1. CNS: Drowsiness 2. Drug hangover 3. Addiction 4. Respiratory depression 5. Physical dependence: Withdrawal symptoms: tremor, seizures, cardiac arrest…. Barbiturates

3. Alcohol Ethanol is an important drug of dependence Acute effect:  CNS: decrease learning ability and attention  GIT: diluted- stimulate gastric secretion. Conc- decrease gastric secretion  CVS: increase HR and CO  Metabolism: Hypoglycemia and metabolic acidosis Chronic effect:  GIT: cirrhosis of liver, gastritis  CNS: acohol withdrwal  Myopathy 2. Hypnotic and anxiolytics Drugs

3. Alcohol Drugs to treat alcohol dependence 1. Disulfiram: blocks the oxidation of acetaldehyde to acetic acid by inhibiting aldehyde dehydrogenase (accumulation of acetaldehyde in the blood, causing flushing, tachycardia, hyperventilation, and nausea) 2. Naltrexone is better tolerated than disulfi ram 2. Hypnotic and anxiolytics Drugs